Diet Matters in Breast Cancer Prognosis: Clinical Trial Evidence and Questions

Clin Cancer Res. 2024 Mar 1;30(5):931-933. doi: 10.1158/1078-0432.CCR-23-3195.

Abstract

Diet and weight matter in breast cancer prognosis. The DIANA-5 randomized controlled trial found no effect of a Mediterranean macrobiotic diet on 5-year breast cancer recurrence, but high adherence was associated with a 41% lower risk of recurrence versus controls. The effects of substantial weight loss on prognosis remain unknown. See related article by Berrino et al., p. 965.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Breast
  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / therapy
  • Diet
  • Female
  • Humans
  • Weight Loss